QUALITATIVE AND QUANTITATIVE COMPOSITION
NEW ZEALAND DATASHEE T . vA11_15May2018 Page 1 of 22. 1. ZYPREXA . ZYPREXA ® film-coated tablet, 2.5 mg, 5 mg, 7.5 mg and 10 mg. ZYPREXA ZYDIS. TM. wafer, 5 mg and 10 mg.
Download QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
CLASSIFICATION AND DRUGS CATEGORY …
apps.who.intCLASSIFICATION AND DRUGS CATEGORY INSTITUTION List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions SECTION 1
Drug, Category, Classification, Institutions, Classification and drugs category, Classification and drugs category institution
Use of Antipsychotics and Other Medications for …
bcbpsd.caTreatment Non-Response: If symptoms persist despite trials of two antipsychotics, or if person does not tolerate antipsychotics, consider referral …
Specified Drugs Regulation RŁglement sur les …
www.gov.mb.caaide À l’achat de mÉdicaments sur ordonnance p115 Š r.m. 6/95 Œact valsartan Œ 40, 80, 160 and 320 mg tablets Œacular Œ 0.5% ophthalmic solution
Drug, Regulations, Tablets, Specified, Mg tablets, Specified drugs regulation
ANTIPSYCHOTIC MEDICATIONS (Atypicals Page 1) …
www.leeheymd.comANTIPSYCHOTIC MEDICATIONS ("Atypicals" Page 2) Used for Psychosis, Schizophrenia, Bipolar Disorder, Severe Impulsive Aggression, Tourette's, Paranoia, Depression, Anxiety, Autism
Name of Medicine - Medsafe
www.medsafe.govt.nzNew Zealand Datasheet Name of Medicine Olanzapine-DRLA film coated tablets Olanzapine ODT-DRLA orodispersible tablets Presentation Olanzapine-DRLA 2.5 mg tablets are white, film coated, oval biconvex tablets
Tablets, Mg tablets, Olanzapine, Olanzapine drla, Drla, Tablets olanzapine
Olanzapine 2.5 mg tablets Olanzapine 5 mg tablets ...
www.mhra.gov.ukUKPAR Olanzapine 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg tablets PL 32854/0015-20 1 Olanzapine 2.5 mg tablets Olanzapine 5 mg tablets Olanzapine 7.5 mg tablets
CARBAGEN Ò 200 MG PRLONGED RELEASE TABLETS
www.medicines.org.ukPackage leaflet: Information for the patient Carbagen® 100 mg Tablets Carbagen® 200 mg Tablets Carbagen® 400 mg Tablets carbamazepine
Sertraline 50 mg film-coated tablets Sertraline 100 …
www.medicines.org.ukPackage leaflet: Information for the user Sertraline 50 mg film-coated tablets Sertraline 100 mg film-coated tablets (Sertraline) P1512438 Black A/s: 195 x 550 mm Read all of this leaflet carefully before you start taking this